QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.106.011361v1 34/12/2064    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zuo, F. Articles by Hattori, M. Search for Related Content PubMed PubMed Citation Articles by Zuo, F. Articles by Hattori, M.

Pharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass Spectrometry

Institute of Natural Medicine (F.Z., N.N., M.H.) and Faculty of Pharmaceutical Sciences (T.A.), University of Toyama, Toyama, Japan

Berberine (Ber) and its main metabolites were identified and quantified using liquid chromatography/electrospray ionization/ion trap mass spectrometry. Rat plasma contained the main metabolites, berberrubine, thalifendine, demethyleneberberine, and jatrorrhizine, as free and glucuronide conjugates after p.o. Ber administration. Moreover, the original drug, the four main metabolites, and their glucuronide conjugates were all detected in liver tissues after 0.5 h and in bile samples 1 h after p.o. Ber administration. Therefore, the metabolic site seemed to be the liver, and the metabolites and conjugates were evidently excreted into the duodenum as bile. The pharmacokinetics of Ber and the four metabolites were determined in conventional and pseudo germ-free rats (treated with antibiotics) after p.o. administration with 40 mg/kg Ber. The AUC_0-limt and mean transit time values of the metabolites significantly differed between conventional and pseudo germ-free rats. The amounts of metabolites were remarkably reduced in the pseudo germ-free rats, whereas levels of Ber did not obviously differ between the two groups. The intestinal flora did not exert significant metabolic activity against Ber and its metabolites, but it played a significant role in the enterohepatic circulation of metabolites. In this sense, the liver and intestinal bacteria participate in the metabolism and disposition of Ber in vivo.

This article has been cited by other articles:

				C.-S. Shia, Y.-C. Hou, S.-H. Juang, S.-Y. Tsai, P.-H. Hsieh, L.-C. Ho, and P.-D. L. Chao Metabolism and Pharmacokinetics of San-Huang-Xie-Xin-Tang, a Polyphenol-rich Chinese Medicine Formula, in Rats and Ex-vivo Antioxidant Activity Evid. Based Complement. Altern. Med., September 8, 2009; (2009) nep124v1. [Abstract] [Full Text] [PDF]

				F. Qiu, Z. Zhu, N. Kang, S. Piao, G. Qin, and X. Yao Isolation and Identification of Urinary Metabolites of Berberine in Rats and Humans Drug Metab. Dispos., November 1, 2008; 36(11): 2159 - 2165. [Abstract] [Full Text] [PDF]

				Y. Zhang, X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, et al. Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2559 - 2565. [Abstract] [Full Text] [PDF]